A
Arcus Biosciences, Inc. (RCUS)
NYQ – Real Time Price. Currency in USD
31.00
+0.75 (2.48%)
At close: Jun 26, 2026, 4:00 PM EDT
31.36
+0.36 (1.16%)
After-hours: Jun 26, 2026, 5:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
31.00
+0.75 (2.48%)
At close: Jun 26, 2026, 4:00 PM EDT
31.36
+0.36 (1.16%)
After-hours: Jun 26, 2026, 5:57 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $201.0M significantly exceed its total debt $113.0M, ensuring strong financial flexibility
Total current assets $844.0M exceed Total current liabilities $209.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-44.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$138.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.04 | 6.05 | 10 | |
| Quick ratio | 4.04 | 5.63 | 10 | |
| Debt to Equity | 0.22 | 0.30 | 8.0 | |
| Debt to Assets | 0.11 | 1.04 | 8.0 | |
| Interest coverage | -44.67 | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 112M | 117M | 258M | 247M | 236M |
| Gross Profit | 98M | 101M | 248M | 237M | 227M |
| Operating Income | -280M | -340M | -310M | -386M | -398M |
| Net Income | -267M | -307M | -283M | -353M | -369M |
| EBITDA | -266M | -324M | -300M | -376M | -389M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -86.12 | N/A | 1.0 |
| Next quarter | -31.24 | 29.46 | 5.5 |
| Current year | -67.63 | -11.81 | 1.0 |
| Next year | -13.33 | 6.39 | 3.0 |
| Weighted average score | 2.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -48.47 | -20.74 | -14.6 | -14.04 | 1.0 |
| Y/Y | -39.28 | -14.28 | 10.53 | -3.75 | 2.5 |
| 3y average | 40.24 | -10.61 | 2.57 | -101.56 | 4.0 |
| 5y average | 88.78 | -98.84 | -96.61 | -82.53 | 3.3 |
| Weighted average score | 2.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |